CollimateHealth
Founded 2026 · 11 employees on LinkedIn · 1 known investors
Find your way into CollimateHealth
1 people in our graph share verified history with the CollimateHealth team — schools, employers, funds. One of them is your warm intro.
CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
Founders & leadership
CollimateHealth was founded in 2026 by Stefan Bartzsch, Johanna Winter, and Hans Maria Heÿn.
SB
Stefan BartzschinCo-founder & Chief Scientific Officer
JW
Johanna WinterinCo-founder & Chief Technology Officer
HM
Hans Maria HeÿninCo-founder & Chief Executive OfficerCo-founder and CEO of CollimateHealth, which develops a clinically scalable microbeam radiation technology for cancer treatment. He has over 15 years of experience in in-vitro diagnostics, medical device, and health-tech development, including MDR and IVDR regulatory requirements and leading international product development teams.
Investors · 1
Frequently asked questions
- What does CollimateHealth do?
- CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
- Who founded CollimateHealth?
- CollimateHealth was founded by Stefan Bartzsch, Johanna Winter, Hans Maria Heÿn in 2026.
- Who are CollimateHealth's investors?
- CollimateHealth's investors include Positron Ventures.